Stay updated with breaking news from Essential Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Essential Pharma Acquires Renaissance Pharma Ltd with Its Clinical Stage Immunotherapy for the Treatment of High-risk Neuroblastoma
Essential Pharma acquires Renaissance Pharma Ltd with its clinical stage immunotherapy for the treatment of high-risk neuroblastoma
Essential Pharma acquires European rights to Colobreathe®(colistimethate sodium) from Teva
Essential Pharma Announces the Appointment of Emma Johnson as Chief Executive Officer Zug, Switzerland & Egham, UK - 24 May 2023 - Essential Pharma, an international specialty pharma company focused
UK marketing authorisations for IOPIDINE® (apraclonidine) fully transferred to Essential Pharma as change in UK NICE guidelines for glaucoma treatment...